 |
|
|
|
|
| Quick Help |
 |
|
|
|
|
| Services |
|
|
|
|
|
|
| Queries |
 |
| Tel1: +91 79 65123395 |
| Tel2: +91 79 26463395 |
| Email: click here |
|
|
 |
 |
  |
|
|
| 2-(imidazo[1,2-a]pyridine -3-yl)acetic acid |
|
| 2-(imidazo[1,2-a]pyridine -3-yl)acetic acid |
| Manus Aktteva Biopharma LLP offers Intermediate of Minodronic Acid, 2-(imidazo[1,2-a]pyridine -3-yl)acetic acid, having cas no 6200-60-8 for your evaluation requirements with supportive technical package required for evaluation |
| Product Reference ID: MA-RG-1190-O |
|
|
| Chemical Name: |
2-(imidazo[1,2-a]pyridine -3-yl)acetic acid |
|
|
| Description |
| CAS number |
6200-60-8 |
| Synonym |
Imidazo[1,2-a]pyridine-3-carboxylic acid |
| Molecular Formula |
C8H6N2O2 |
| Molecular Weight |
162.14 |
| Specifications |
Available on request |
| Packing |
Export worthy packing |
| Application |
Intermediate of Minodronic Acid |
|
|
|
|
|
|
|
|
|
| 6200-60-8, Intermediate of Minodronic Acid, suppliers, manufacturers, India, China |
|
|
|
|
 |
NOTE: 
- Manus Aktteva Biopharma LLP, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
- Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
PATENTS:
- => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
=> Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
|
|
|
|
|